Categories
Health

Dr. Peter Hotez applauds CDC’s endorsement of vaccines for pregnant ladies in gentle of harmful antivaccine rhetoric

Dr. Peter Hotez told CNBC he was glad the Centers for Disease Control and Prevention updated their guidelines and urged pregnant women to get vaccinated, especially given the widespread misinformation campaigns targeting pregnant women.

“Unfortunately, the bad guys, the anti-vaccine groups, have published a lot of fake information claiming that Covid-19 vaccines can cause infertility,” said Hotez, co-director of the vaccine development center at Texas Children’s Hospital.

“They copied and pasted their fake news about the HPV vaccine for cervical cancer and other cancers, which was also wrong, that they said caused infertility, and they just copied / pasted it right on Covid-19 vaccines . There was never any truth to it. “

The CDC’s recommendation comes because the highly transmissible Delta variant is causing a further increase in Covid-19 infections and the daily cases nationwide are rising over 100,000. According to CDC statistics, by July 31, around 23% of pregnant women had received at least one dose of the Covid vaccine.

Hotez underlined in an interview on Wednesday evening in “The News with Shepard Smith” how dangerous it is for some pregnant women to become infected with Covid-19.

“We have seen many and many pregnant women over the past year and a half who got very sick, went to the pediatric intensive care unit, lost their baby, lost their own life to Covid-19, and this is the really scary piece” “, said Hotez. “Pregnant women have not coped well with this virus, and that is the big message.”

Categories
Health

Elon Musk’s Neuralink backed by Google Ventures, Peter Thiel, Sam Altman

SpaceX Founder and Chief Engineer Elon Musk speaks during the Satellite 2020 Conference in Washington, DC, the United States on March 9, 2020.

Yasin Öztürk | Anadolu Agency | Getty Images

Elon Musk’s brain-machine interface company Neuralink has raised $ 205 million from investors including Google Ventures, Peter Thiels Founders Fund and OpenAI CEO Sam Altman.

The Series C round, announced in a blog post on Thursday, was led by Dubai-based Vy Capital.

It comes two years after Neuralink raised $ 51 million. The total investment in the company now amounts to $ 363 million, according to the start-up tracker Crunchbase.

Founded in 2016, Neuralink seeks to develop high bandwidth brain implants that can communicate with phones and computers.

The company is targeting quadriplegics with its first devices – who cannot interact with many of today’s devices – and is working on human studies.

“The first clue this device is for is to help quadriplegics regain their digital freedom by allowing users to interact with their computers or phones in high bandwidth and naturally,” it says.

So far, the technology has been tested on pigs and a monkey that could play the video game pong with its mind.

The company said its first product, known as the N1 Link, will be “completely invisible” after implantation and will transmit data over a wireless connection. Musk, who is the CEO of Neuralink as well as Tesla and SpaceX, previously described Neuralink as a Fitbit in your skull with tiny wires going into your brain.

“The funds from the round will be used to bring Neuralink’s first product to market and accelerate research and development on future products,” said Neuralink.

Keeping up with AI

Neuralink said Thursday its mission is to “develop brain-machine interfaces that treat various brain disorders, with the ultimate goal of creating an entire brain interface that can more closely connect biological and artificial intelligence.”

AI is only getting smarter, and Musk previously said that Neuralink’s technology could one day allow people to “ride on”.

People are practically already “cyborgs” because they have a tertiary “digital layer” thanks to telephones, computers and applications, he said during a clubhouse discussion in February.

“With a direct neural interface, we can improve the bandwidth between your cortex and your digital tertiary layer by many orders of magnitude,” said Musk. “I would say probably at least 1,000 or maybe 10,000 or more.”

The cortex is a part of the brain that plays a key role in memory, attention, perception, thinking, language, and awareness. The digital plane he is referring to can be anything from a person’s iPhone to their Twitter account.

Long-term, Musk claims that Neuralink could enable humans to use telepathy to send concepts to each other and after death to exist in a “stored state” that could then be plugged into a robot or other human. He admitted he was breaking into science fiction territory.

Musk said the Neuralink device will be operational

Neuralink demo

Several other companies are also developing brain-computer interfaces, including Blackrock Neurotech, supported by Thiel and his friend Christian Angermayer.

Elsewhere, scientists from the University of Melbourne have already achieved some success with brain-computer interfaces.

A university study in October showed that two people thought about controlling a computer with a stentrode (a small array of electrodes mounted on a stent) developed by Australian biotech company Synchron, without having to shave and pierce the skull.

The Stentrode brain-computer interface enabled two people with amyotrophic lateral sclerosis – a rare neurological disorder – to type, text messages, email, online banking, and make online purchases through thoughts.

Categories
Health

Third Covid shot could also be approach round masking, says Dr. Peter Hotez

Dr. Peter Hotez told CNBC that while the Centers for Disease Control and Prevention’s new Covid masking guidelines are “absolutely” necessary to battle the delta variant and surging cases, there might be an alternative to wearing masks indoors again. 

“There is potentially a way to get around it, and it may be that third immunization,” said Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital.

The vaccines are currently proving to hold up against symptomatic illness and against serious illness, ICU admissions and hospitalizations. Hotez, however, noted that the vaccines “are not holding up as well” when it comes to stopping asymptomatic transmission, because the delta variant is so highly contagious. 

New data shows that people infected with the delta strain can carry up to 1,000 times more virus in their nasal passages than those infected with the original strain.

CDC Director Rochelle Walensky said Tuesday recent studies show that those vaccinated individuals who do become infected with Covid have just as much viral load as the unvaccinated, making it possible for them to spread the virus to others.

Hotez explained to “The News with Shepard Smith” that the booster shot could increase the virus- neutralizing antibodies in people who have been vaccinated, and that is important because it could help stop asymptomatic transmission. 

Categories
World News

Peter de Vries, Dutch Crime Reporter, Dies After Being Shot

AMSTERDAM — A Dutch crime reporter who was shot in the head in a brazen attack in central Amsterdam last week as he was leaving a television studio, died of his wounds on Thursday, his family said in a statement. The reporter, Peter R. de Vries, was 64.

“Peter has fought until the end, but has been unable to win this battle,” the statement, carried by the Dutch broadcast news service RTL Nieuws, said. “We are indescribably proud of him and at the same time inconsolable.”

Mr. de Vries, a well-known public figure in the Netherlands, was shot on the evening of July 6 by an unknown assailant. The attack led to broad condemnation in the country, where drug related crime and shootings have steadily increased over the last decade. European leaders have condemned the shooting, which raised questions about protections for journalists.

The police arrested two men last week in connection with the attack after stopping them in a car on a nearby highway. The police identified the suspects as a 35-year-old Polish citizen and a 21-year-old from Rotterdam. The police have said they believe the younger man was the gunman

Both suspects appeared in court in Amsterdam on Friday and they remain in custody.

Ferd Grapperhaus, the Dutch justice minister, called Mr. de Vries a “brave man” and said his death was “nothing less than a direct attack on our society.”

Mr. de Vries, who had hosted a televised crime show for nearly two decades and has long been known in the Netherlands for solving cold cases, had said he regularly received death threats.

The television show on which Mr. de Vries appeared before he was shot last week did not air last Friday, after threats from criminals who said they wanted to target the studio using automatic weapons or a rocket launcher, according to Dutch news media. The show has resumed its daily episodes, but will be recorded elsewhere, the network reported.

Mr. de Vries began his journalism career in 1978 at De Telegraaf, a popular Dutch newspaper. A decade later, he published a book on the kidnapping of the beer magnate Freddy Heineken. He covered many high-profile cases, including the 2005 disappearance of an Alabama teenager, Natalee Holloway, in Aruba, a Caribbean island that is part of the Netherlands; and a decades-long investigation into the rape and murder of an 11-year-old boy, Nicky Verstappen.

His television show, “Peter R. de Vries, Crime Reporter,” which began in 1995 and aired for 17 years, was his real breakthrough.

Most recently, Mr. de Vries had set up a foundation in the hopes of solving the 1993 disappearance of Tanja Groen, a young woman who vanished on her way home from a party. On Tuesday, Dutch public television aired a special program where viewers donated hundreds of thousands of euros to the cause.

Mr. de Vries, who was also the director of a law office, had been an adviser over the past year to a key witness in a trial over killings said to have been ordered by a criminal organization. The main defendant in the case, Ridouan Taghi, who is accused of leading the organization, was arrested in Dubai in 2019.

Derk Wiersum, a lawyer for the same key witness in that trial, was killed in Amsterdam in 2019. The witness’s brother was shot dead in 2018.

Amsterdam and other Dutch cities have been the scene of several shootings over the past decade in which criminals have targeted either each other or those interfering in their crimes. The nearby port of Rotterdam is one of the key gateways for importing cocaine into Europe, and the country is a leader in the illegal production of amphetamines and crystal meth.

Categories
Entertainment

Peter Zinovieff, Composer and Synthesizer Innovator, Dies at 88

Peter Zinovieff, a composer and inventor whose pioneering synthesizers shaped albums by Pink Floyd, David Bowie, Roxy Music and Kraftwerk, died on June 23 in Cambridge, England. He was 88.

His death was announced on Twitter by his daughter Sofka Zinovieff, who said he had been hospitalized after a fall.

Mr. Zinovieff oversaw the design of the first commercially produced British synthesizers. In 1969, his company, EMS (Electronic Music Studios), introduced the VCS3 (for “voltage controlled studio”), one of the earliest and most affordable portable synthesizers. Instruments from EMS soon became a staple of 1970s progressive-rock, particularly from Britain and Germany. The company’s slogan was “Think of a sound — now make it.”

Peter Zinovieff was born on Jan. 26, 1933, in London, the son of émigré Russian aristocrats: a princess, Sofka Dolgorouky, and Leo Zinovieff. His parents divorced in 1937.

Peter’s grandmother started teaching him piano when he was in primary school. He attended Oxford University, where he played in experimental music groups while earning a Ph.D. in geology. He also dabbled in electronics.

“I had this facility of putting pieces of wire together to make something that either received or made sounds,” he told Red Bull Music Academy in 2015.

He married Victoria Heber-Percy, then 17, who came from a wealthy family. She and her parents were unhappy with the extensive travel that a geologist’s career required. After Mr. Zinovieff worked briefly for the Air Ministry in London as a mathematician, he turned to making electronic music full time, supported by his wife.

He bought tape recorders and microphones and found high-quality oscillators, filters and signal analyzers at military-surplus stores. Daphne Oram, the electronic-music composer who was a co-founder of the BBC Radiophonic Workshop, taught him techniques of making music by splicing together bits of sound recorded on magnetic tape in the era of musique concrète.

But Mr. Zinovieff decided that cutting tape was tedious. He built a primitive sequencer — a device to trigger a set of notes repeatedly — from telephone-switching hardware, and he began working on electronic sequencers with the electrical engineers Mark Dowson and David Cockerell. They realized that early digital computers, which were already used to control factory processes, might also control sound processing.

Mr. Zinovieff’s wife sold her pearl and turquoise wedding tiara for 4,000 British pounds — now about $96,000 — to finance Mr. Zinovieff’s purchase of a PDP-8 computer designed by the Digital Equipment Corporation. Living in Putney, a district of London, Mr. Zinovieff installed it in his garden shed, and he often cited it as the world’s first home computer. He added a second PDP-8; the two units, which he named Sofka and Leo, could control hundreds of oscillators and other sound modules.

The shed was now an electronic-music studio. Mr. Cockerell was an essential partner; he was able to build the devices that Mr. Zinovieff envisioned. Mr. Cockerell “would be able to interpret it into a concrete electronic idea and make the bloody thing — and it worked,” Mr. Zinovieff said in the 2006 documentary “What the Future Sounded Like.”

In 1966, Mr. Zinovieff formed the short-lived Unit Delta Plus with Delia Derbyshire (who created the electronic arrangement of Ron Grainer’s theme for the BBC science fiction institution “Doctor Who”) and Brian Hodgson to make electronic ad jingles and other projects.

The programmer Peter Grogono, working with Mr. Cockerell and Mr. Zinovieff, devised software to perform digital audio analysis and manipulation, presaging modern sampling. It used numbers to control sounds in ways that anticipated the Musical Instrument Digital Interface (MIDI) standard that was introduced in 1983.

On Jan. 15, 1968, Mr. Zinovieff brought his computer to Queen Elizabeth Hall in London for Britain’s first public concert of all-electronic music. His “Partita for Unattended Computer” received some skeptical reviews: The Financial Times recognized a technical achievement but called it “the dreariest kind of neo-Webern, drawn out to inordinate length.”

Mr. Zinovieff lent a computer to the 1968 exhibition “Cybernetic Serendipity” at the Institute of Contemporary Arts in London. Visitors could whistle a tune and the computer would analyze and repeat it, then improvise variations.

Continually upgrading the Putney studio was expensive. Mr. Zinovieff offered to donate the studio’s advanced technology to the British government, but he was ignored. To sustain the project, he and Mr. Cockerell decided to spin off a business.

So in 1969, Mr. Zinovieff, Mr. Cockerell and Tristram Cary, an electronic composer with his own studio, formed EMS. They built a rudimentary synthesizer the size of a shoe box for the Australian composer Don Banks that they later referred to as the VCS1.

In November, they unveiled the more elaborate VCS3, also known as the Putney. It used specifications from Mr. Zinovieff, a case and controls designed by Mr. Cary and circuitry designed by Mr. Cockerell (who drew on Robert Moog’s filter design research). It was priced at 330 pounds, about $7,700 now.

Yet the VCS3 was smaller and cheaper than other early synthesizers; the Minimoog didn’t arrive until 1970 and was more expensive. The original VCS3 had no keyboard and was best suited to generating abstract sounds, but EMS soon made a touch-sensitive keyboard module available. The VCS3 also had an input so it could process external sounds.

Musicians embraced the VCS3 along with other EMS instruments.

EMS synthesizers are prominent in songs like Pink Floyd’s “On the Run,” Roxy Music’s “Virginia Plain” and Kraftwerk’s “Autobahn,” and the Who used a VCS3 to process the sound of an electric organ on “Won’t Get Fooled Again.” King Crimson, Todd Rundgren, Led Zeppelin, Tangerine Dream, Aphex Twin and others also used EMS synthesizers.

“I hated anything to do with the commercial side,” Mr. Zinovieff told Sound on Sound magazine in 2016. He was more interested in contemporary classical uses of electronic sound. In the 1970s, he composed extensively, but much of his own music vanished because he would tape over ideas that he expected to improve.

He also collaborated with contemporary composers, including Harrison Birtwistle and Hans Werner Henze. “I didn’t want to have a commercial studio,” he said in 2010. “I wanted an experimental studio, where good composers could work and not pay.” Mr. Zinovieff and Mr. Birtwistle climbed to the top of Big Ben to record the clock mechanisms and gong sounds they incorporated in a quadraphonic 1971 piece, “Chronometer.”

Like other groundbreaking synthesizer companies, EMS had financial troubles. It filed for bankruptcy in 1979 after branching into additional products, including a video synthesizer, a guitar synthesizer and a vocoder.

Mr. Zinovieff handed over his full studio — including advanced prototypes of an interactive video terminal and a 10-octave pressure-sensitive keyboard — to the National Theater, in London, which belatedly found that it couldn’t raise funds to maintain it. The equipment was dismantled and stored for years in a basement, and it was eventually ruined in a flood.

Mr. Zinovieff largely stopped composing for decades. During that time he taught acoustics at the University of Cambridge.

But he wasn’t entirely forgotten. He worked for years on the intricate libretto for Mr. Birtwistle’s 1986 opera “The Mask of Orpheus,” which included a language Mr. Zinovieff constructed using the syllables in “Orpheus” and “Eurydice.”

In 2010, Mr. Zinovieff was commissioned to write music for a sculpture in Istanbul with 40 channels of sound. “Electronic Calendar: The EMS Tapes,” a collection of Mr. Zinovieff’s work and collaborations from 1965 to 1979 at Electronic Music Studios, was released in 2015.

Mr. Zinovieff learned new software, on computers that were exponentially more powerful than his 1970s equipment, and returned to composing throughout the 2010s, including pieces for cello and computer, for violin and computer and for computer and the spoken word. In 2020, during the pandemic, he collaborated with a granddaughter, Anna Papadimitriou, the singer in the band Hawxx, on a death-haunted piece called “Red Painted Ambulance.”

Mr. Zinovieff’s first three marriages ended in divorce. He is survived by his fourth wife, Jenny Jardine, and by six children — Sofka, Leo, Kolinka, Freya, Kitty and Eliena — and nine grandchildren.

A former employee, Robin Wood, revived EMS in 1997, reproducing the vintage equipment designs. An iPad app emulating the VCS3 was released in 2014.

Even in the 21st century, Mr. Zinovieff sought better music technology. In 2016, he told Sound on Sound that he felt limited by unresponsive interfaces — keyboards, touchpads, linear computer displays — and by playback through stationary, directional loudspeakers. He longed, he said, for “three-dimensional sound in the air around us.”

Categories
Health

Peter Thiel-backed psychedelic start-up’s shares pop in Wall Avenue debut

Peter Thiel-backed psychedelic start-up Atai Life Sciences soared on Friday on its first day of trading on Wall Street.

The newly listed Nasdaq stock opened 40% before falling a little.

The German biotech company’s IPO on Thursday evening was $ 15 per share, the upper end of the expected range. The company, which aims to make psychedelic drugs for the treatment of mental disorders, raised $ 225 million on a valuation of $ 2.3 billion.

Atai is the third psychedelic biotech company to go public in the US, following in the footsteps of MindMed, which went public on Nasdaq in April, and Founder Fund-funded Compass Pathways, which listed in September were. As of Thursday’s close, Compass Pathways is up 26% since it debuted, and MindMed, which was just announcing the resignation of its CEO, has been down about 19% since it went public.

Each biotech develops therapies with the psychedelic mushroom compound psilocybin, LSD and MDMA derivatives for the treatment of addiction and mental illnesses such as depression, anxiety, schizophrenia and traumatic brain injuries. Three years after its inception, Atai Life Sciences has 10 therapeutic programs in its pipeline, each in different phases of clinical trials.

Atai founder and chairman Christian Angermayer said Friday on CNBC’s “Squawk Box”: “The world we are building is a bad place for our brains, so mental health problems will increase. Portfolio to end the mental health crisis . “

Investor interest in psychedelic treatments has grown as the medical community’s interest in these therapies has grown.

Centers for psychedelics and psychology include Johns Hopkins University, Yale University, University of California, Berkeley, and the Icahn School of Medicine. Recent studies showing MDMA’s promise in treating post-traumatic stress disorder and the effectiveness of psilocybin, a hallucinogenic chemical found in psychedelic mushrooms, in treating drug-resistant depression have only increased interest in the area.

Angermayer was an early investor in Compass Pathways, and his own company, Atai, serves as the holding company for various psychedelic startups seeking alternative treatments for mental illness. He told CNBC on Friday that new age biotechs are building on centuries of practice in shamanic cultures and religions.

There are currently federal restrictions on psychedelic mushrooms, MDMA – commonly known as molly or ecstasy – and LSD around the world. However, Oregon became the first US state to legalize psychedelics for therapeutic use last year. Washington, DC residents also recently voted to decriminalize the use of psychedelics for medical purposes.

Atai Life Sciences listed on Nasdaq for its IPO on June 18, 2021.

Source: Nasdaq

Angermayer insists that government approval of these drugs for therapeutic purposes for the mentally ill could make a big difference. “They are very, very strong drugs, but they must be taken under supervision. … You will trip while sitting with your therapist.”

Atai Life Sciences are, among others, the billionaire Thiel as well as Mike Novogratz’s Galaxy Investments and Angermayer’s own Apeiron Investment Group.

According to venture capital tracker CB Insights, VC deals in psychedelics have grown significantly over the past three years: less than $ 100 million in venture capital was invested in psychedelic startups in 2018 and 2019, but $ 346 million in 2020. By April 2021, VCs had already invested $ 329 million in the industry.

It’s no wonder Atai’s was oversubscribed more than 12 times, according to a market source that asked to remain anonymous due to the nature of the discussion. “A good part was taken over by existing investors,” said the person, adding that Thiel was the largest existing investor and that he would be “doubled” when it went public.

Mutual fund Palo Santo said it made a notable stake in Atai’s initial public offering. “There is an urgent need to address our broken mental health system,” said Daniel Goldberg, co-founder of Palo Santo, in a statement. “We believe psychedelics will expand treatment options and transform the outdated system.”

Atai filed an S-1 filing with the Securities and Exchange Commission in April that showed it raised a total of $ 362.3 million from private investors at the time.

The company, which describes itself as a drug development platform, was founded to acquire, incubate, and develop psychedelics and other drugs used to treat depression, anxiety, addiction, and other mental illnesses.

Atai, which employs around 50 people in offices in Berlin, New York and San Diego, currently works with 14 companies focused on drug development and other technologies.

In exchange for a controlling interest in the drugs and technologies they develop, Atai helps scientists raise money, work with regulators, and conduct clinical trials. None of Atai’s drugs have yet been officially approved by regulatory agencies.

Thiel invested $ 11.9 million in Atai in November through his venture firm Thiel Capital.

“Atai’s great virtue is to take mental illness as seriously as we should all have taken illnesses all along,” said Thiel, the co-founder of Palantir and PayPal, in a statement shared with CNBC at the time. “The company’s most valuable asset is its sense of urgency.”

Categories
World News

Marketing campaign launched to get Peter Thiel’s agency out of NHS

Peter Thiel, co-founder and chairman of Palantir Technologies Inc., pauses during a news conference in Tokyo, Japan, on Monday, Nov. 18, 2019.

Kiyoshi Ota | Bloomberg | Getty Images

LONDON — A campaign is being launched to try to stop U.S. tech giant Palantir from working with the U.K.’s National Health Service.

The “No Palantir in Our NHS” campaign — launched at an event on Thursday — comes after Palantir partnered with the NHS on a Covid-19 “Data Store.” The project was designed to help the government and health service use data to monitor the spread of the virus.

Foxglove, which describes itself as a tech-justice nonprofit, is leading the campaign, while over 50 other organizations working on civil liberties, anti-racism, migrant justice and public health have also backed it.

“We got dozens of organizations to realize and agree that this company has no place in the NHS in the long term,” Cori Crider, the lawyer who co-founded Foxglove, told CNBC on Wednesday.

Palantir, which has been criticized by privacy campaigners and human rights groups on multiple occasions, declined to comment when contacted by CNBC. A spokesperson for the NHS did not respond.

What is Palantir?

Founded in 2003 by tech entrepreneurs including billionaire Peter Thiel — a Facebook board member who reportedly donated $1.25 million to Donald Trump’s presidential campaign — Palantir sells software that’s designed to help public and private organizations analyze huge quantities of data and pull out meaningful patterns and connections.

Since its inception, the $45 billion publicly listed company has supported spy agencies, border forces and militaries, with the finer details of contracts often kept a closely guarded secret.

In April 2018, Bloomberg published an article headlined: “Palantir Knows Everything About You.”

Named after the fictional “seeing stones” in “Lord of the Rings,” Palantir has been linked to everything from efforts to track down undocumented immigrants in the United States to the development of unmanned drones for bombings and intelligence.

“Their background has generally been in contracts where people are harmed, not healed,” Crider said.

Clive Lewis, a Labour Party member of Parliament and one of the campaign’s backers, accused Palantir of having an “appalling track record.”

“It’s built its business supporting drone and missile strikes, immigration raids and arrests, not the delivery and care of medicine,” Lewis told CNBC. “It’s got a questionable agenda, and I think that will have a negative impact on patient trust, particularly among minoritized communities who may feel a threat from big government.”

Palantir — which has been trying to grow its European business in recent years — has a significant presence in London’s Soho neighborhood, with hundreds of employees across multiple offices in the area.

Covid-19 Data Store

The Covid-19 Data Store project, which involves Palantir’s Foundry data management platform, began in March 2020 alongside other tech giants as the government tried to slow the spread of the virus across the U.K. It was sold as a short-term effort to predict how best to deploy resources to deal with the pandemic.

The contract was quietly extended in December when the NHS and Palantir signed a £23 million ($34 million) two-year deal that allows the company to continue its work until December 2022.

The NHS was sued by political website openDemocracy in February over the contract extension. “December’s new, two-year contract reaches far beyond Covid: to Brexit, general business planning and much more,” the group said.

The NHS Covid-19 Data Store contract allows Palantir to help manage the data lake, which contains everybody’s health data for pandemic purposes.

“The reality is, sad to say, all this whiz-bang data integration didn’t stop the United Kingdom having one of the worst death tolls in the western world,” said Crider. “This kind of techno solution-ism is not necessarily the best way of making an NHS sustainable for the long haul.”

Patient data is “pseudonymized” before it is processed by Palantir’s software as part of an effort to protect patient privacy. The data management technique involves switching the original data set, with an alias or pseudonym. However, it is a reversible process that allows for re-identification in the future if necessary and some have questioned whether it’s enough. Palantir may argue that it isn’t interested in the patient data itself and that it only provides the platform that allows the NHS to analyze the data.

While Palantir is processing the patient data, the NHS remains the data owner, limiting what Palantir can do with it.

Pivot to health

There have been some signs that government appetite for limitless spend on security has started to wane and Palantir may have lost a couple of deals as a result, Crider said, pointing to a report in The Guardian that highlights some of the difficulties the EU’s law agency had with Palantir’s software.

Crider believes the firm has been trying to find new sources of government contracts beyond security as a result. “They hit on a new possibility, which was health data,” she said.

The company was reportedly lobbying officials from the U.K. Department of Trade as well as health executives back in 2019. But it struggled to secure any contracts.

When the pandemic hit, however, the laws changed so that data sharing was done in a mandatory way and for the first time in U.K. history everyone’s data was pooled into a huge lake. Procurement rules were also reportedly changed. “Palantir pounced and they managed to get in,” Crider said, adding that there was no bid or competitive tender.

Palantir’s interest in health was highlighted again on Thursday when it emerged in a Financial Times report that the company has taken a strategic stake in British health firm Babylon as part of a $4.2 billion blank-check deal to take the start-up public in the U.S.

Babylon CEO Ali Parsa told the newspaper that “nobody” has brought some of the tech that Palantir owns “into the realm of biology and healthcare.” Parsa, whose app offers a variety of health care services to 24 million patients, added: “Their knowledge of healthcare can overhaul what we could do [together]. We wanted to take … the day to day biometrics of the human body and be able to construct a more pre-emptive image, by building a digital twin of each of us.”

A boy runs past a mural supporting the NHS, by artist Rachel List, on the gates of the Hope & Anchor pub in Pontefract, Yorkshire, as the UK continues in lockdown to help curb the spread of the coronavirus.

Danny Lawson | Getty Images

Crider believes the U.K. is at an inflexion point when it comes to health data.

From July 1, the NHS is planning to pool the full medical histories of 55 million patients in England into a single database that will be available to academic and third parties for research and planning purposes. Patients have until June 23 to opt out. Campaigners said Friday the “data grab” violates patient trust and they’re threatening to take legal action.

“The British public need to realize that we are now coming into a period where the future of the NHS health data, and the health data settlement of this country, is now kind of up for grabs and up for debate,” Crider said. “Companies have seen it for a while. Palantir don’t want to monetize the data they want to monetize the infrastructure, but there are other companies who absolutely do want to monetize access to the data.”

Categories
Health

Political ideology is actual cause folks stay unvaccinated, says Dr. Peter Hotez

Dr. Peter Hotez argued that the real reason some Americans don’t get vaccinated is because of their political ideology.

“They unfortunately tie their political loyalty to the political right. And we see this in the bottom ten states in terms of vaccination rates,” which is half the coverage in the top ten states, said Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital.

The ten states with the highest rate of residents receiving at least one dose of Covid-19 vaccine also voted for President Joe Biden in the 2020 presidential election. Polls show that more than 40% of Republicans don’t plan to be vaccinated.

Hotez told CNBC’s The News with Shepard Smith that regional summer flare-ups in states with lower vaccination rates could lead the Centers for Disease Control and Prevention to urge Americans to wear masks again.

The CDC on Thursday relaxed mask guidelines for the US, saying that fully vaccinated people no longer need to wear a face mask or stay 6 feet away from others in most environments, whether outdoors or indoors.

The updated guidelines have received widespread criticism, but Hotez said this was because the new guidelines arrived earlier than expected.

“I was expecting it sometime in June, so it’s a couple of weeks early,” said Hoetz. “I think it will be fine. But I think the shops, the corporations and the universities need a little time to get information and have internal discussions.”

Categories
Entertainment

‘Peter Grimes’ Sails on Uneven Seas of Brexit and the Pandemic

In Madrid, the British singers welcomed the opportunity to appear in a major “Peter Grimes” production with about 150 artists at a time when most opera houses in Europe and the United States were closed, but they also sounded concerned about what would come after that would come .

James Gilchrist, who sings the role of a priest in Britten’s opera, said 90 percent of his work was in the European Union rather than the UK, which worried him not only about his own future but also about the prospects for younger artists. “If you’re a promoter in Frankfurt or something, you’re not going to want to put a British artist on the top of your list because it’s such a hassle,” he said.

“For very established artists this is probably less of a problem as their name on the poster gets people in, but if you are more early in your career I think this will be very, very difficult. ”

Matabosch said the Teatro Real strives to have the best possible line-up regardless of nationality. He predicted that post-Brexit travel rules would be easier to navigate, but conceded that British artists risked losing substitution work, which is an important part of their income.

“I’m sure that in the end we will know exactly how to get a British singer across, just like people from Australia or Canada come here. The problem, however, is that if you need a last minute replacement and you have to fly over someone that same morning it is not really feasible from the UK at the moment, ”said Matabosch.

Another British member of the Peter Grimes cast, John Graham-Hall, thanked the Teatro Real for helping them overcome travel hurdles that left him with “a very bad feeling that the British government was not interested in the arts “. He also gave a brief summary of the twin hurdles posed by Brexit and the pandemic: “It’s a bloody nightmare.”

Alex Marshall contributed to coverage from London

Categories
World News

Peter Thiel criticizes Google and Apple for being too near China

Peter Thiel, Co-Founder and Chairman of Palantir Technologies Inc., speaks during a press conference in Tokyo, Japan on Monday, November 18, 2019.

Kiyoshi Ota | Bloomberg | Getty Images

Tech investor Peter Thiel criticized major US tech companies for being too close to China when they appeared at a virtual Richard Nixon Foundation event on Tuesday.

Co-founder of PayPal and after an early investment on the Facebook board of directors, Thiel is an outspoken voice in the technology investment world known for opposing opinions and conservative leanings. He has supported defense companies like Palantir and publicly endorsed former President Donald Trump’s 2016 presidential campaign.

On Wednesday, the Nixon session focused on China, and he was accompanied by former Secretary of State Mike Pompeo and former National Security Advisor Robert O’Brien.

Thiel criticized Google for its work on artificial intelligence with Chinese universities, in part based on conversations it allegedly had with insiders of the company, according to a transcript of the CNBC-reviewed event.

“Since everything in China is a civil-military merger, Google has worked effectively with the Chinese military, not the American military,” said Thiel. He’s also sad that Google “insiders” told him they worked with the Chinese because “they thought they might as well hand the technology off on their doorstep because if they didn’t give it, it would be stolen anyway . “

A Google spokesman told CNBC, “These allegations are baseless. We do not partner with the Chinese military. We are proud to continue our long history of working with the US government, including the Department of Defense, in many areas, including cybersecurity , Recruitment and health care. “

Thiel had already criticized Google in 2019 and said that the FBI and the CIA should investigate Google and ask whether it had been compromised by Chinese spies.

Thiel also said Apple is unlikely to confront China due to its massive supply chain for making iPhones and other products in the country. He noted that other big tech companies like Facebook, Amazon, and Microsoft don’t have as extensive business interests in the country, in some cases because the Chinese government has curtailed their options there.

He called on the US to put “a lot of pressure” and control on Apple because there is a labor supply chain in the country.

“Apple is probably the one that is structurally a real problem, since the entire iPhone supply chain consists of China,” said Thiel. “Apple has real synergies with China.”

During the conversation, he also appeared to change his position on Bitcoin. Thiel has invested in Bitcoin companies and previously said he was “Long Bitcoin” and considered it the “digital equivalent of gold”.

On Tuesday, Thiel said that Bitcoin is threatening the US dollar.

“Although I’m a kind of pro-crypto-pro-Bitcoin maximalist, I wonder if Bitcoin should also be partially thought of as a Chinese financial weapon against the US, where it threatens fiat money, but it threatens the US in particular Dollars, and China wants to do things to weaken it, so China’s long Bitcoin, “said Thiel.